| Toxicity of ZnO nanoparticles in healthy adult mice M Esmaeillou, M Moharamnejad, R Hsankhani, AA Tehrani, H Maadi Environmental toxicology and pharmacology 35 (1), 67-71, 2013 | 233 | 2013 |
| Mechanisms underlying the action and synergism of trastuzumab and pertuzumab in targeting HER2-positive breast cancer B Nami, H Maadi, Z Wang Cancers 10 (10), 342, 2018 | 190 | 2018 |
| Trastuzumab mechanism of action; 20 years of research to unravel a dilemma H Maadi, MH Soheilifar, WS Choi, A Moshtaghian, Z Wang Cancers 13 (14), 3540, 2021 | 136 | 2021 |
| The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application … H Kahroba, B Ramezani, H Maadi, MR Sadeghi, H Jaberie, F Ramezani Ageing research reviews 65, 101211, 2021 | 111 | 2021 |
| In vivo toxicity of orally administrated silicon dioxide nanoparticles in healthy adult mice R Hassankhani, M Esmaeillou, AA Tehrani, K Nasirzadeh, F Khadir, ... Environmental Science and Pollution Research 22, 1127-1132, 2015 | 85 | 2015 |
| The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2 H Maadi, B Nami, J Tong, G Li, Z Wang BMC cancer 18, 1-14, 2018 | 74 | 2018 |
| Prevalence of Brucellosis in cattle in Urmia, Irán. H Maadi, M Moharamnejad, M Haghi | 60 | 2011 |
| DNA damage repair response in mesenchymal stromal cells: from cellular senescence and aging to apoptosis and differentiation ability H Kahroba, H Sadeghzadeh, DM Wilson III, H Maadi, N Samadi, ... Ageing research reviews 62, 101125, 2020 | 50 | 2020 |
| Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer H Maadi, A Moshtaghian, MF Taha, SJ Mowla, A Kazeroonian, NK Haass, ... The international journal of biochemistry & cell biology 81, 121-132, 2016 | 47 | 2016 |
| Angioregulatory microRNAs in colorectal cancer MH Soheilifar, M Grusch, HK Neghab, R Amini, H Maadi, M Saidijam, ... Cancers 12 (1), 71, 2019 | 41 | 2019 |
| The effects of pertuzumab and its combination with trastuzumab on HER2 homodimerization and phosphorylation B Nami, H Maadi, Z Wang Cancers 11 (3), 375, 2019 | 32 | 2019 |
| Polyethylenimine-coated iron oxide magnetic nanoparticles for high efficient gene delivery AH Nguyen, GN Abdelrasoul, D Lin, H Maadi, J Tong, G Chen, R Wang, ... Applied Nanoscience 8, 811-821, 2018 | 24 | 2018 |
| Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies MH Soheilifar, N Masoudi-Khoram, S Madadi, S Nobari, H Maadi, ... Journal of Advanced Research 37, 235-253, 2022 | 21 | 2022 |
| BMI1 roles in cancer stem cells and its association with microRNAs dysregulation in cancer: Emphasis on colorectal cancer MH Soheilifar, A Moshtaghian, H Maadi, F Izadi, M Saidijam International Journal of Cancer Management 11 (9), 2018 | 17 | 2018 |
| Analysis of cell cycle by flow cytometry H Maadi, MH Soheilifar, Z Wang Cell-Cycle Synchronization: Methods and Protocols, 183-195, 2022 | 16 | 2022 |
| Effect of alternating and direct currents on Pseudomonas aeruginosa growth in vitro H Maadi, M Haghi, R Delshad, H Kangarloo, MA Mohammadnezhady, ... African Journal of Biotechnology 9 (38), 6373-6379, 2010 | 16 | 2010 |
| A novel mechanism underlying the inhibitory effects of trastuzumab on the growth of HER2-positive breast cancer cells H Maadi, Z Wang Cells 11 (24), 4093, 2022 | 14 | 2022 |
| Dimerization assessment of epithelial growth factor family of receptor tyrosine kinases by using cross-linking reagent H Maadi, B Nami, Z Wang ErbB Receptor Signaling: Methods and Protocols, 101-108, 2017 | 6 | 2017 |
| Investigation on the seroprevalence and pollution severity to Brucella abortus and Brucella melitensis bacteria in cows and sheeps living in the villager region of … M Rezaei, SH Mohebali, YK Abadi, E Suri, A Zare, SH Malamir, ES Rasuli, ... | 4 | 2010 |
| Overcoming retinoic acid resistance in HER2‐enriched breast cancers: role of MYC WS Choi, RZ Liu, C Mak, H Maadi, R Godbout The FEBS Journal 291 (15), 3521-3538, 2024 | | 2024 |
